SCHEMBL17737354

SCHEMBL17737354

O=C(C[C@H]1CC[C@H](c2ccccc2)CC1)Nc1ccc(Cl)cc1F

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 2/20 0.67
▸ KMT2A Q03164 4/20 0.51
▸ ALDH1A1 P00352 2/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ NPC1 O15118 3/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ CHRM1 P11229 1/20 0.45
▸ MAPT P10636 3/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ LMNA P02545 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ PKM P14618 1/20 0.45
▸ RAB9A P51151 3/20 0.44
▸ EPHX2 P34913 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.43
▸ RORC P51449 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20838661 1.00 IDO1 (0.67) IDO1KMT2AALDH1A1L3MBTL1NPC1
SCHEMBL17737049 1.00 IDO1 (0.67) IDO1KMT2AALDH1A1L3MBTL1NPC1
SCHEMBL20852681 1.00 IDO1 (0.67) IDO1KMT2AALDH1A1L3MBTL1NPC1
SCHEMBL20838623 0.86 ALDH1A1 (0.56) IDO1KMT2AALDH1A1L3MBTL1NPC1
SCHEMBL17737375 0.86 ALDH1A1 (0.56) IDO1KMT2AALDH1A1L3MBTL1NPC1
SCHEMBL17737420 0.86 ALDH1A1 (0.56) IDO1KMT2AALDH1A1L3MBTL1NPC1
SCHEMBL28171777 0.83 IDO1 (0.62) IDO1ALDH1A1NPC1SMN1; SMN2CHRM1
SCHEMBL20838647 0.80 IDO1 (1.00) IDO1KMT2AALDH1A1NPC1SMN1; SMN2
SCHEMBL17737348 0.80 IDO1 (1.00) IDO1KMT2AALDH1A1NPC1SMN1; SMN2
SCHEMBL20838648 0.80 IDO1 (1.00) IDO1KMT2AALDH1A1NPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11932601-B2 Immunoregulatory agents FLEXUS BIOSCIENCES, INC. (US) 2024-03-19 — — US claimed
US-20220274926-A1 IMMUNOREGULATORY AGENTS FLEXUS BIOSCIENCES INC (US) 2022-09-01 — — US claimed
US-11932601-B2 Immunoregulatory agents FLEXUS BIOSCIENCES, INC. (US) 2024-03-19 — — US disclosed
US-20220274926-A1 IMMUNOREGULATORY AGENTS FLEXUS BIOSCIENCES INC (US) 2022-09-01 — — US disclosed
US-11242319-B2 Immunoregulatory agents FLEXUS BIOSCIENCES, INC. (US) 2022-02-08 — — US disclosed
US-11242319-B2 Immunoregulatory agents FLEXUS BIOSCIENCES, INC. (US) 2022-02-08 — — US disclosed
US-20190092729-A1 IMMUNOREGULATORY AGENTS FLEXUS BIOSCIENCES, INC. 2019-03-28 — — US disclosed
US-20190092729-A1 IMMUNOREGULATORY AGENTS FLEXUS BIOSCIENCES, INC. 2019-03-28 — — US disclosed
WO-2016073738-A2 IMMUNOREGULATORY AGENTS FLEXUS BIOSCIENCES, INC. (US) 2016-05-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11242319-B2 Immunoregulatory agents IDO1, IDO2, INMT IDO1 1/4885KMT2A 1557/4885ALDH1A1 219/4885
US-20190092729-A1 IMMUNOREGULATORY AGENTS IDO1, IDO2, INMT IDO1 1/4885KMT2A 1557/4885ALDH1A1 219/4885
US-11932601-B2 Immunoregulatory agents IDO1, IDO2, INMT IDO1 1/4885KMT2A 1557/4885ALDH1A1 219/4885
US-20220274926-A1 IMMUNOREGULATORY AGENTS IDO1, IDO2, INMT IDO1 1/4885KMT2A 1557/4885ALDH1A1 219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback